Cargando…
Endogenous programmed death ligand-1 restrains the development and onset of Sjӧgren’s syndrome in non-obese diabetic mice
Programmed death-ligand 1 (PD-L1) down-modulates various immune responses by engaging the co-inhibitory receptor programmed death-1. Expression of PD-L1 and programmed death-1 is elevated in the salivary glands of patients with Sjögren’s syndrome (SS). The objective of this study is to define the ro...
Autores principales: | Zhou, Jing, Jin, Jun-O., Kawai, Toshihisa, Yu, Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5155421/ https://www.ncbi.nlm.nih.gov/pubmed/27966604 http://dx.doi.org/10.1038/srep39105 |
Ejemplares similares
-
Evaluation of patients with dry eye for the presence of primary or secondary Sjӧgren’s syndrome
por: Abd-Allah, Nashwa M, et al.
Publicado: (2019) -
Parameters of Somatosensory Evoked Potentials in Patients with Primary Sjӧgren's Syndrome: Preliminary Results
por: Dziadkowiak, Edyta, et al.
Publicado: (2018) -
Mitochondrial double-stranded RNAs as a pivotal mediator in the pathogenesis of Sjӧgren’s syndrome
por: Yoon, Jimin, et al.
Publicado: (2022) -
The impact of Sjӧgren’s syndrome on the quality of sexual life of female patients in the UK: a controlled analysis
por: Al-Ezzi, Minan, et al.
Publicado: (2021) -
Effects of subconjunctival administration of anti-high mobility group box 1 on dry eye in a mouse model of Sjӧgren’s syndrome
por: Kim, Kyeong Hwan, et al.
Publicado: (2017)